Elphis Cell Therapeutics
PrivateLast Round
Series A
Extension
Jan 21, 2024
Total Funding Raised
$6.72M
Company Overview
Elphis Cell Therapeutics is a biotechnology company that develops personalized cell therapies for intractable vascular diseases using complex stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elphis Cell Therapeutics Comparables
Compare Elphis Cell Therapeutics with similar companies based on industry and business-model similarity.
Elphis Cell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 21, 2024 | ||||
| Series A | Oct 12, 2023 |
Elphis Cell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BSK Investment | Series A |
| Pathfinder H | Series A Extension, Series A |
| The Turning Point | Series A |
| Daekyo Investment | Series A, Series A Extension |
| LK Technology Investment | Series A |
Elphis Cell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elphis Cell Therapeutics's valuation, stock price, and market status.